Measurement of in Vivo Mitochondrial Capacity in Infants

Stopped early

Conditions studied: Healthy Infants

In brief

The overarching aim of this project is to determine the test re-test reliability of 31P-magnetic resonance spectroscopy measurements in infants. Primary endpoints include two separate measures of in vivo mitochondrial capacity (ATPmax) over a 1-10 day period to assess feasibility and reliability.

Key facts

Study ID

NCT03976596

Run by

Pennington Biomedical Research Center

People needed

2

Starts

2019-05-21

Expected to finish

2019-07-02

Last updated by the study team

2026-02-03

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy, full-term infant
• aged 14-28 days at Visit 1
• willingness of parents to be notified of incidental findings from study procedures

You may not qualify if…

• born preterm
• implanted metal or electronic objects that render MRI unsafe
• unable to complete 2 clinic visits 1-10 days apart at Pennington Biomedical Research Center

Where it is running

• Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.